Fisher & Paykel Healthcare

Over the past two decades, our understanding of high flow therapy has evolved, resulting in the F&P Optiflow Duet™ Asymmetric interface. Learn more on our website https://bit.ly/3AMBii5

The F&P Optiflow Junior 2+ XXL Nasal Interface features larger tubing than the Optiflow Junior 2 to offer the potential for using higher flow rates up to 50 L/min. Learn more about Optiflow Junior 2+: https://bit.ly/4cEfKBV

For neonates greater than 28 weeks’ gestational age, there is emerging evidence supporting the use of nasal high flow (NHF) for primary respiratory support with 'rescue' continuous positive airway pressure (CPAP) available. Learn more about NHF in the neonatal space: https://bit.ly/45Ywpxs

The F&P myAirvo™ 2 humidified high flow therapy system has shown clinical results in improving the quality of life and reducing the AECOPD rate of patients by 37% over one year (Storgaard et al., 2018). Learn more about how the myAirvo 2 device can benefit your patients at https://lnkd.in/gwKhYqvG #WorldCOPDAwarenessDay #COPDAwareness #myAirvo #HFNC

Our Auckland campus is bustling with activity as we welcomed 116 interns into our teams. Over the summer, they will dive into hands-on projects and help make a difference to millions of patients all over the world. We can’t wait to see you innovate, grow and contribute to F&P! #FPHcareers #CaretoMakeaDifference #Summerinterns #Internship

An evolution in our understanding of high flow therapy over two decades has resulted in the F&P Optiflow Duet™ Asymmetric™ interface. Attending #aarccongress2024? Come and learn about the Optiflow Duet interface at booth #611 or find out more on our website https://lnkd.in/g5wJpWvg

Join us for the latest episode in F&P’s educational webinar series, @ Home with Humidified High Flow, featuring Tracy Foo, MSc of Fisher & Paykel Healthcare on Thursday, 14 November, 2024, 11am (PT), 1pm (CT), 2pm (ET). To register for this CEU eligible Zoom webinar, please visit https://lnkd.in/g823QMwJ During this webinar, we will cover: • Reviewing the mechanisms of action for Humidified High Flow Therapy. • Discussing the clinical applications and supporting evidence of HHFT for chronic COPD patients. • Reviewing the fundamental concept of Asymmetric HHFT. • Discussing the impact of Asymmetric HHFT on the physiology of a chronic COPD patient. • Evaluating the clinical evidence supporting Asymmetric HHFT

Bubble CPAP, a mode of CPAP therapy, may offer an additional benefit to babies in that it generates pressure oscillations that may improve gas exchange and carbon dioxide (CO2) elimination. CPAP can be used in both the acute and recovery phases of respiratory distress syndrome (RDS) in neonates and infants. Learn more about bubble CPAP: https://bit.ly/3xFR257

Try the Airvo 3 high flow device on your phone. Explore a user interface simulation, navigate the menu system, and confidently test settings. Download the app directly from the App Store or Google Play now: http://qr.fph.co/bf8lc6 Only available in some countries. #makeyourflowmatter

Compared with self-inflating bags, T-piece resuscitators such as the F&P Neopuff deliver a more controlled and consistent PIP and PEEP, which helps to protect a newborn’s lungs, and establish functional residual capacity. Learn more about the Neopuff here: https://bit.ly/4eXC8rC